NeuroOne Medical Technologies Corporation

Founded in 2009 and headquartered in Eden Prairie, US, NeuroOne Medical Technologies specializes in creating innovative medical devices.15 mn.NeuroOne specializes in the development of high-definition, minimally invasive diagnostic and therapeutic devices utilizing a unique thin-film electrode technology. Their flagship product, the OneRF™ Radiofrequency Ablation System, is designed for creating radiofrequency lesions in nervous tissue, specifically targeting functional neurosurgical procedures such as those for epilepsy. This system offers physicians enhanced capabilities for bedside monitoring, mapping, and ablation, ultimately aiming to improve therapeutic outcomes for patients suffering from drug-resistant epilepsy. Additionally, NeuroOne's Evo® sEEG and Evo® Cortical Electrodes provide advanced solutions for temporary brain monitoring and mapping, enhancing surgical implant options while reducing infection risks.45 mn. The company’s revenue model revolves around the direct sale of its specialized medical devices to healthcare institutions, focusing on long-term partnerships with hospitals and surgical centers. They are targeting expansion into international markets, particularly in Europe and Asia, within the next two years. This strategy aligns with their commitment to enhancing their product portfolio and reaching more healthcare providers globally.

1. Seed

   Mar 14, 2017

   Amount

   $1.2M

   Investors

   Locked